CAS number: 2353-33-5
Our Controlled Substance and API portfolio is supported by a global network of GMP facilities: West Deptford, NJ; Devens, MA; North Andover, MA; Edinburgh, UK and Annan, UK.
Myelodysplastic Syndromes (MDS)
* Monographs are available on request
† Regulatory filings are available on request